1350 related articles for article (PubMed ID: 9489619)
1. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
2. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
Brunner F; Schmidt K; Nielsen EB; Mayer B
J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
[TBL] [Abstract][Full Text] [Related]
3. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
4. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
Prieto D; Simonsen U; Hernández M; García-Sacristán A
Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
6. BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine]-induced dilation in ovine pulmonary artery: role of sodium pump.
Bawankule DU; Sathishkumar K; Sardar KK; Chanda D; Krishna AV; Prakash VR; Mishra SK
J Pharmacol Exp Ther; 2005 Jul; 314(1):207-13. PubMed ID: 15792996
[TBL] [Abstract][Full Text] [Related]
7. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
[TBL] [Abstract][Full Text] [Related]
8. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B
Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433
[TBL] [Abstract][Full Text] [Related]
9. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
Wegener JW; Gath I; Förstermann U; Nawrath H
Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
Schrammel A; Behrends S; Schmidt K; Koesling D; Mayer B
Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100
[TBL] [Abstract][Full Text] [Related]
11. The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum.
Göçmen C; Büyüknacar HS; Kots AY; Murad F; Kiroglu O; Kumcu EK
J Pharmacol Exp Ther; 2006 Feb; 316(2):753-61. PubMed ID: 16254132
[TBL] [Abstract][Full Text] [Related]
12. Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase.
Schindler U; Strobel H; Schönafinger K; Linz W; Löhn M; Martorana PA; Rütten H; Schindler PW; Busch AE; Sohn M; Töpfer A; Pistorius A; Jannek C; Mülsch A
Mol Pharmacol; 2006 Apr; 69(4):1260-8. PubMed ID: 16332991
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle.
Ijioma SC; Challiss RA; Boyle JP
Br J Pharmacol; 1995 Jul; 115(5):723-32. PubMed ID: 8548169
[TBL] [Abstract][Full Text] [Related]
14. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
Ding KH; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582
[TBL] [Abstract][Full Text] [Related]
15. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate.
Hussain AS; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 1997 Aug; 75(8):1034-7. PubMed ID: 9360020
[TBL] [Abstract][Full Text] [Related]
16. Blockade of nitrergic neuroeffector transmission in guinea-pig colon by a selective inhibitor of soluble guanylyl cyclase.
Olgart C; Hallén K; Wiklund NP; Iversen HH; Gustafsson LE
Acta Physiol Scand; 1998 Jan; 162(1):89-95. PubMed ID: 9492906
[TBL] [Abstract][Full Text] [Related]
17. BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro.
Kalsi JS; Rees RW; Hobbs AJ; Royle M; Kell PD; Ralph DJ; Moncada S; Cellek S
J Urol; 2003 Feb; 169(2):761-6. PubMed ID: 12544359
[TBL] [Abstract][Full Text] [Related]
18. Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea.
Li L; Vaali K; Paakkari I; Vapaatalo H
Br J Pharmacol; 1998 Apr; 123(7):1337-42. PubMed ID: 9579728
[TBL] [Abstract][Full Text] [Related]
19. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide regulation of guanosine-3',5'-cyclic monophosphate production in human endothelial cells.
Rautureau Y; Gowers I; Wheeler-Jones CP; Baxter GF
Auton Autacoid Pharmacol; 2010 Jul; 30(3):185-92. PubMed ID: 20085572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
